๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Breast conserving therapy in stage I & II breast cancer in Korea

โœ Scribed by Hy-De Lee; Dong-Sup Yoon; Ja-Yun Koo; Chang-Ok Suh; Woo-Hee Jung; Ki-Keun Oh

Book ID
110229439
Publisher
Springer US
Year
1997
Tongue
English
Weight
40 KB
Volume
44
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Breast conserving therapy in stage I and
Breast conserving therapy in stage I and II breast cancer
โœ Z. Rancห‡iฤ‡; M. Jeremiฤ‡; M. Stojiljkoviฤ‡; M. Pesห‡iฤ‡; N. Djordjeviฤ‡; D. Gmijoviฤ‡; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 142 KB
Breast-conserving therapy for Stage I-II
Breast-conserving therapy for Stage I-II synchronous bilateral breast carcinoma
โœ Smitha V. Gollamudi; Rebecca S. Gelman; Gloria Peiro; Lindsey J. Schneider; Stua ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB ๐Ÿ‘ 2 views

up for surviving patients was 95 months (range, 68-157 months). Pathology slides were available for review in 19 cases. Cosmetic results and complications after 1 Joint Center for Radiation Therapy and Depart-BCT were scored. Outcome was compared with that of 1314 patients with unilateral ment of Ra

Breast-conserving therapy (BCT) for earl
Breast-conserving therapy (BCT) for early-stage breast cancer
โœ Rashmi K. Benda; Nancy Price Mendenhall; D. Scott Lind; Juan C. Cendan; Barbara ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB

## Abstract Several patient and tumor factors go into the decision process to determine whether a breast cancer patient is a good candidate for breastโ€conserving therapy. The patient must be seen by all disciplines before any therapeutic intervention. When used appropriately, breastโ€conserving ther